Why the study?
Does intramuscular halothane injection increase local Pco(2) concentrations in malignant hyperthermia susceptible individuals compared to non-susceptible individuals?
Does intramuscular halothane injection increase local Pco(2) concentrations in malignant hyperthermia susceptible individuals compared to non-susceptible individuals?
Intramuscular halothane injection with local Pco2 measurement is a promising minimally invasive metabolic test to diagnose malignant hyperthermia susceptibility.
Answers are grounded in this paper and cite their sources.
May support minimally invasive MH testing; leaves open diagnostic accuracy and safety before clinical adoption.
We hypothesised that intramuscular halothane injection increases local Pco(2) concentrations in malignant hyperthermia susceptible (MHS) but not in non-susceptible (MHN) individuals. Pco(2) probes with attached microtubing catheters for halothane injection were placed into the lateral vastus muscle of eight MHS and eight MHN probands. Following equilibration, a single bolus of 200 microl halothane 5 and 6 vol% was injected. Pco(2) was measured spectrophotometrically. Baseline Pco(2) concentrations were similar between groups. Maximum Pco(2) and maximum rate of Pco(2) increase was significantly enhanced by halothane 5 and 6 vol% in MHS compared to MHN probands. Systemic haemodynamic and metabolic parameters did not differ between both groups. Local halothane application induces a hypermetabolic reaction with a significant Pco(2) increase in MHS compared to MHN probands, indicating a susceptibility to malignant hyperthermia. Intramuscular halothane injection with Pco(2) measurement seems to be a suitable method for the development of a minimally invasive metabolic test to diagnose malignant hyperthermia susceptibility.
No takes yet. Share an insight, caveat, or question.
Schuster et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: